TQB3525
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TQB3525, covering 2020-12-31 to 2020-12-31. Get the full timeline:
Most recent: Clinical Trial Update: TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN Loss [Phase 1, Phase 2]